Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer.
J Immunother Emphasis Tumor Immunol
; 18(3): 188-95, 1995 Oct.
Article
in En
| MEDLINE
| ID: mdl-8770775
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-2
/
Neoplasms
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Immunother Emphasis Tumor Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
/
NEOPLASIAS
Year:
1995
Document type:
Article
Affiliation country:
France